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Abstract
Background: Capturing dimensions of physical activity relevant to patients may provide a unique perspective for
clinical studies of chronically ill patients. However, the quality of the development of existing instruments is
uncertain. The aim of this systematic review was to assess the development process of patient-reported outcome
(PRO) instruments including their initial validation to measure physical activity in chronically ill or elderly patient
populations.
Methods: We conducted a systematic literature search of electronic databases (Medline, Embase, Psychinfo, Cinahl)
and hand searches. We included studies describing the original development of fully structured instruments
measuring dimensions of physical activity or related constructs in chronically ills or elderly. We broadened the
population to elderly because they are likely to share physical activity limitations. At least two reviewers
independently conducted title and abstract screening and full text assessment. We evaluated instruments in terms
of their aim, items identification and selection, domain development, test-retest reliability, internal consistency,
validity and responsiveness.
Results: Of the 2542 references from the database search and 89 from the hand search, 103 full texts which
covered 104 instruments met our inclusion criteria. For almost half of the instruments the authors clearly described
the aim of the instruments before the scales were developed. For item identification, patient input was used in
38% of the instruments and in 32% adaptation of existing scales and/or unsystematic literature searches were the
only sources for the generation of items. For item reduction, in 56% of the instruments patient input was used and
in 33% the item reduction process was not clearly described. Test-retest reliability was assessed for 61%, validity for
85% and responsiveness to change for 19% of the instruments.
Conclusions: Many PRO instruments exist to measure dimensions of physical activity in chronically ill and elderly
patient populations, which reflects the relevance of this outcome. However, the development processes often
lacked definitions of the instruments’ aims and patient input. If PROs for physical activity were to be used in clinical
trials more attention needs to be paid to the establishment of content validity through patient input and to the
assessment of their evaluative measurement properties.
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Physical activity is crucial to chronically ill patients’
functioning in daily life. The evidence of the protective
role of physical activity for the prevention and manage-
ment of chronic diseases has been well established over
recent decades [1,2]. Physical activity is a multidimen-
sional construct and defined as “any bodily movement
produced by the contraction of skeletal muscle that
increases energy expenditure above a basal level” [3].
The assessment of physical activity as an outcome
measure provides a unique perspective in chronic dis-
ease research not only for observational studies, but also
for drug and nondrug clinical trials. Furthermore, evi-
dence from trials regarding physical activity as a patient-
reported outcome (PRO) could inform patients about
treatment options that address relevant aspects of their
daily life. Investigators who are interested in measuring
physical activity face the challenge of not only choosing
an instrument that serves their study aim, but that has
also been carefully developed and validated. These
instruments should have strong psychometric properties
such as stability over time (test-retest reliability) and the
capacity to detect even small effects (responsiveness to
change). In addition, investigators need to be certain
that the instruments reflect the dimensions of physical
activity that are relevant to patients.
It is currently unclear whether available instruments
to measure physical activity fulfil these requirements.
Therefore, the aim of this systematic review, which is
part of the Innovative Medicines Initiative PROactive
project (http://www.proactivecopd.com a project
jointly funded by the European Commission and the
European Federation of Pharmaceutical Industries and
Associations ‘EFPIA), was to identify existing fully
structured PROs (questionnaires, scales) measuring
physical activity (frequency, intensity and total
amount), and/or symptoms (physical and mental) or
complaints/concerns associated with physical activity
in chronically ill or elderly patient populations. We
broadened the population to elderly because they are
likely to share some characteristics regarding physical
activity with chronically ill patients. Furthermore, the
systematic review aimed to evaluate the methodologi-
cal rigour with which the retrieved instruments were
developed and initially validated as a part of the devel-
opment process. Therefore, we restricted our review to
the first validations of the instruments as part of the
development process. In this paper we focused on the
methods used in the development of the physical
activity instruments. The content and the format of
the included instruments are reviewed in another
paper.
Methods
A study protocol (unregistered) guided the entire review
process. We followed standard systematic review metho-
dology as outlined in the handbooks of the Centre for
Reviews and Dissemination [4] and the Cochrane Colla-
boration. The reporting follows the PRISMA statement
that recently replaced the former guidelines of reporting
of systematic reviews and meta-analyses (QUOROM
statement) [5].
Eligibility criteria
We considered the following criteria for inclusion and
exclusion:
Population
We included PRO instruments developed for patients
with chronic disease or elderly people. Elderly people
were included because chronic illnesses usually affect
people in later stages of life. In addition, we supplemen-
ted the electronic database search with explicit search
terms for COPD patients. This is because this systematic
review is part of the PROactive project, which aims to
develop and validate two PRO instruments for COPD
patients [6].
Types of instrument
We included fully structured instruments (scales or
questionnaires) with standardised questions and answer
options which were reported by the patient (self-
reported). We only included interviewer administered
instruments if the information was self-reported by the
patient and we excluded instruments that required a rat-
ing by an interviewer.
Content of instrument/assessment of physical activity
We included instruments measuring dimensions of phy-
sical activity or related constructs. We considered the
following definition for physical activity according to the
U.S. Department of Health and Human Services [3]:
“Physical activity is defined as any bodily movement
produced by the contraction of skeletal muscle that
increases energy expenditure above a basal level”.T h i s
definition of physical activity is broad and encompasses
activities of daily living, sports and activities for personal
fulfilment. We did not restrict the search to instruments
measuring the frequency, intensity and total amount of
physical activity, but also considered instruments asses-
sing “related constructs” and/or subscales that focused
on symptoms (physical and mental) or complaints/con-
cerns associated with physical activity. All of the instru-
ments we included contained at least one physical
activity subscale. We only included instruments whose
items we could access from the publication or from the
developers. We did not have any language or publication
date restrictions.
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We included both cross-sectional and longitudinal stu-
dies which described the development (including item
generation, piloting etc) or modifications of the original
instrument and the initial validation (psychometric
properties, cross-sectional or longitudinal) of the origi-
nal instrument. Since we focused on the methods used
for the development process of the instruments, the arti-
cle had to describe a minimum of the development or
first validation process, for example, a description about
item identification or selection and/or at least one
assessment of test-retest, responsiveness or validity in a
publication that was clearly the original. We excluded
studies that used an eligible instrument as an outcome
measure and were not designed to initially validate this
instrument. We also excluded studies that reported the
validation of instruments in additional languages and/or
populations.
Information sources
Electronic database searches
We searched the electronic databases Medline, Embase,
PsycINFO and CINAHL on September 18th 2009.
Hand searches
We conducted the following hand searches to comple-
ment the electronic database search results: We
searched for original development studies of instruments
from articles which were excluded for the reason “vali-
dation only” or “used as outcome measures"; we scanned
the reference lists of the full texts; we searched the
Patient-Reported Outcome and Quality of Life Instru-
ments Database (PROQolid) on March 10 2010, search
term: “physical functioning” questionnaires; and we con-
tacted experts in the field and asked them to check if
our list of included instruments was complete or if we
missed any instruments.
Search
For the electronic database search, we used the follow-
ing search terms: (physical activity OR functioning OR
function OR motor activity OR activities of daily living
OR walking OR activity OR exercise) AND (question-
naire* OR scale OR instrument OR tool OR diary OR
assessment OR self-report OR measure*) AND (valid*)
AND (chronic disease OR elderly OR COPD OR
chronic lung disease OR chronic obstructive lung dis-
ease) NOT (athletic performance OR sports OR children
OR adolescent).
Study selection
Title and abstract screening
Two pairs of two reviewers each used a title and
abstract screening document to independently review
the title and abstract of every article retrieved by the
database search. Decisions to include or exclude were
recorded in the RefWorks-COS file (0 = exclude, 1 =
order for full text assessment, 2 = only validation study
of existing instrument, 3 = related study (e.g. reviews),
do not order but may be useful reference). We ordered
all articles that were deemed potentially eligible by at
least one reviewer.
Full text screening
Two pairs of two reviewers each independently evaluated
the full texts and made a decision on inclusion or exclu-
sion according to the predefined selection criteria. They
recorded their decision on a paper form together with the
reason for exclusion (not relevant patient group; instru-
ment does not measure dimensions of physical activity or
related constructs; instrument is not self-reported (e.g.
functional or exercise test like time to stand up from a
chair or 6 minutes walking test); instrument with all its
items is not available from the publication or from the
developers; instrument is used as an outcome measure/
study is not designed to validate this instrument, respec-
tively; validation study only (e.g. additional languages,
populations etc.); other). If the two reviewers could not
agree, a third reviewer decided whether to include or
exclude. Studies that did not fulfil all of the predefined cri-
teria were excluded and their bibliographic details were
listed with the specific reason for exclusion.
Piloting the study selection process
Initially, all reviewers piloted the selection process by
applying the inclusion and exclusion criteria to the 50
first references for titles and abstracts screening and the
first 30 papers for full text assessment. Inclusion and
exclusion criteria were refined and clarified based on
this piloting process.
Dealing with lack of information
We made three attempts to contact authors by e-mail in
the following conditions: 1) If it was unclear from the
full text article whether the study fulfilled the inclusion
and exclusion criteria; 2) If the included development
study lacked information on how the instrument was
developed in order to complete data extraction; 3) If the
included development study lacked information on the
instrument’s content (items, introduction question,
recall period etc.). If we failed to retrieve the relevant
information from the author, this was reported on the
data extraction form.
Dealing with duplicate publications
In cases where multiple papers were published (e.g.
translations, reporting on different outcomes etc.), we
treated the study with multiple reports as a single study
but made reference to all publications.
Data extraction process
We created standardised data extraction forms based on
a form used in a previous review [7] to record the
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tion forms were piloted twice by four reviewers includ-
ing 8 instruments for the first and 6 instruments for the
second pilot. The forms and categories were then
adapted and refined where necessary. The first reviewers
extracted the data and stored it in a MS Word file. The
second reviewers then independently extracted the data
a n dc o m p a r e dt h e i rr e s u l t sw i t ht h a to ft h ef i r s t
reviewers. These changes were made using the ‘track
changes’ m o d e .T h ef i l ew a ss e n tb a c kt ot h ef i r s t
reviewer in order to come to an agreement. When an
agreement could not be reached a third reviewer was
consulted.
Data extraction
We extracted data from the development studies regard-
ing the instruments’ development and initial validation
process. We used pre-defined categories and answer
options including numerical indications, fixed texts such
as “yes/no”, multiple choice and free text. We extracted
data for the following categories:
Development of instruments
Aim of instrument We distinguished between 3 cate-
gories: First, if the aim of the instrument was clearly
described by the authors before the instrument was
developed, the classification was “described”.W ed i f f e r -
entiated between the four aims “evaluative” (detection of
changes over time, typically for evaluation of treat-
ments), “discriminative” (detection of differences
between patients, e.g. for phenotyping), “predictive”
(prediction of future health outcomes, e.g. hospital
admissions or death) and “planning” (planning of treat-
ment, e.g. detection of areas with low scorings to target
patient education accordingly). Second, if the aim was
not explicitly described by the authors before develop-
ment but could be identified from the context, the clas-
sification was “not clearly described, but presumably (e.
g. evaluative)”. Third, if the purpose of the instrument
was not reported and could not be identified we used
the classification “not described”.
Identification of items To describe the identification of
the items, we differentiated between five categories of
sources of item generation (several answer options possi-
ble): patients and elderly (target population); experts (e.g.
clinical experts, health professionals, care givers etc., also
includes supplementation or modification of existing
items through experts); significant others (e.g. family
members, care givers); literature; and adaptation of exist-
ing instruments. We also described the method of item
identification in brackets, for example, interviews or
focus groups, systematic or unsystematic searches.
Selection of items We reported the approach used by
the authors to select items for the final instrument by
differentiating between the following four sources:
patients quantitative; patients qualitative; experts quanti-
tative; experts qualitative. We provided specific details
in brackets, for example, “Patients: quantitative (e.g. fac-
tor analysis)”, “Patients: qualitative (e.g. focus group)”,
“Experts: quantitative (e.g. relevance)” or “Experts: quali-
tative (e.g. interviews)”.
Development of domains We recorded the method of
how the domains were defined, i.e. if they were defined
a priori (the authors predefined domains and items
which belong to these domains without statistical ana-
lyses but based on their clinical/research experience or
opinion) or if domains were statistically defined by fac-
tor analysis.
Initial validation of instruments
Test-retest We recorded if test-retest reliability (repro-
ducibility) was examined and described the statistical
method used, for example, intra-class correlation coeffi-
cients, coefficient of variation, Pearson or Spearman cor-
relation coefficients or t-tests.
Internal consistency We recorded if internal consis-
tency reliability was assessed and described the statistical
method used, for example, Cronbach’s alpha, corrected
item total correlation or Cronbach’s alpha excluding
item analysis.
Validity We recorded if validity was assessed and if so,
the type of validity that the authors described to assess
(in quotation marks) and the statistical methods used
(in brackets).
Responsiveness We recorded any approaches to assess
responsiveness (i.e. the ability of an instrument to detect
changes over time) and we reported the statistical meth-
ods used.
Minimal important difference (MID) We reported if
the MID was examined and the statistical methods (e.g.
anchor- or distribution-based approaches) used.
Summary of conducted initial validation assessments
according to aim of instrument The aim of the instru-
ment determines the measurement properties, which
should be assessed in the validation process. The assess-
ment of test-retest reliability and internal consistency is
important for each instrument development, regardless
of whether the instrument’s aim is evaluative, discrimi-
native, predictive or planning. For instruments with an
evaluative aim, the longitudinal testing of the validity is
of special interest whereas for instruments with discri-
minative or planning aims, cross-sectional testing of the
validity is sufficient. For instruments with evaluative
aims, the assessment of responsiveness and the MID is
crucial because they aim to detect changes over time.
We summarised the assessed psychometric properties
of the instruments for which the authors clearly
described an aim before the instruments was developed.
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We described the results of the data extraction in struc-
tured tables according to the categories described above
(see Additional file 1). We synthesised the data on the
instruments’ development and initial validation in a nar-
rative way and in integrated tables. We used numbers
and proportions to describe the results quantitatively.
These frequencies were calculated using SPSS (Version
18.0).
Results
Study selection
Figure 1 shows the flow diagram of the identification of
the studies. The electronic database search produced
2542 references. After title and abstract screening, 2268
of these were excluded resulting in 274 articles for full
text assessment. This included 5 Japanese and one Chi-
nese language article which were provisionally included
due to their English abstract but were not included in
the current analysis as we were unable to translate them
[8-13]. Hand searches of reference sections and of
excluded articles revealed an additional 70 instruments/
development studies for full text assessment. The search
of the PROQolid database produced a further 58 instru-
ments, 19 of which were included for full text assess-
ment after title and abstract screening. One additional
instrument was retrieved from the consultation with
experts. Therefore, a total of 364 papers were included
for full text assessment.
Following full text assessment, a further 255 were
excluded resulting in 104 instruments from 103 full
texts (the article of Mannerkorpi & Hernelid (2005) [14]
provided information for the development process of
two instruments) included in the review [14-117]. The
most frequent reasons for exclusion were instrument is
not self-reported (n = 71), followed by instrument does
not measure physical activity (n = 66), validation study
only (n = 35) and instrument used as an outcome mea-
sure (n = 29). The references of all excluded articles
after full text assessment are summarised in Additional
file 2.
Study characteristics
Additional file 1 summarises the extracted data for the
development and initial validation process of the
reviewed instruments.
Aim of instrument
For almost half of the instruments (n = 49, 47.1%), the
authors clearly described the aim of the instruments
before the scales were developed. One aim was
described for 26 instruments (53.1%) and more than one
for 23 instruments (46.9%). The most frequently
described aim was evaluative (n = 33), followed by dis-
criminative (n = 26), planning (n = 13) and predictive (n
= 5). For 43.3% of the instruments (n = 45), the authors
did not clearly describe one or several aims but they
could be presumed from the context (presumably discri-
minative: n = 32, presumably evaluative: n = 24, pre-
sumably planning: n = 9, presumably predictive: n = 9).
For 10 instruments (9.6%), the authors did not describe
an aim.
Identification of items
For 39 instruments (37.5%) items were identified with
patient input, either with patient input only or with
patient input together with other sources (adaptation of
existing instruments, experts and/or literature). Adapta-
tion of existing instruments and/or unsystematic litera-
ture searches only were the source for item
identification of 33 instruments (31.7%), and expert
input only or expert input additionally to literature and
adaptation was the source for item identification of 14
instruments (13.5%). For the development of 18 instru-
ments (17.3%), item identification was not reported or
not clearly described. Table 1 describes the sources
which were used to identify the items of the included
instruments, ordered by frequency.
The most frequently used method to generate patient
input was “interviews with patients” only (for 24 of 39
instruments). Focus groups were less frequently con-
ducted (for 5 of 39 instruments) and for only 1 instru-
ment both interviews and focus groups were conducted.
For 7 instruments, the method of generating patient
input was not reported and for 2 instruments, patient
input was described as “clinical interactions” or “open
ended survey”. The methods used to obtain expert input
were more diverse and varied from interviews with
experts to workshops, ratings of relevance, unspecified
discussions and undefined consideration of clinical opi-
nion. Literature searches were always conducted
unsystematically.
Selection of items
For 58 instruments (55.8%), patient input was used for
item reduction, and for 12 instruments (11.5%) the
items were selected by expert input only. For 34 instru-
ments (32.7%), item reduction was not clearly described
(see Table 2). Where patient input was used for item
selection (n = 58), the methods were predominantly
quantitative (n = 31, 53.4%) and conducted by factor
analysis (17 of 31 instruments). Less frequently used
methods included item-total correlations, Rasch analyses
and consideration of response rates and floor/ceiling
effects. Qualitative methods, either alone or in addition
to quantitative methods, were used in the selection of
items for 46.6% (n = 27) of the instruments. Most fre-
quently, qualitative patient input for item selection was
generated by patient interviews (10 of 27 instruments).
Less frequently focus groups and cognitive interviews/
debriefings were used.
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The domains were more often developed by factor ana-
lysis (n = 36, 34.6%) than by a priori specifications (n =
16, 15.4%). For half of the instruments, the development
of the domains was not reported (n = 42, 40.4%) or was
not applicable (n = 8, 7.7%). The domains of two instru-
ments were developed by Rasch analysis.
Test-retest
Test-retest reliability was assessed for 63 instruments
(60.6%). The most frequently used statistical methods
were intraclass correlation coefficients either alone (n =
18) or together with other methods (n = 5). This was
followed by Pearson correlation coefficient (n = 10),
unspecified correlations (n = 9), various types of t-tests
Figure 1 Flow diagram of identification of studies.
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various other methods (n = 15). 41 development studies
(39.4%) did not report on assessing test-retest reliability.
Internal consistency
Internal consistency was assessed in 62 development
studies (59.6%). Most frequently internal consistency
was assessed by Cronbach’s alpha alone (n = 46) or
Cronbach’s alpha together with other methods (n = 10).
Validity
Eighty-eight studies reported on the assessment of valid-
ity (84.6%). The most frequently assessed type of validity
that the authors described was construct validity (n =
43), followed by convergent/convergence validity (n =
19), discriminant validity (n = 18), concurrent validity (n
= 16), content validity (n = 12), criterion validity (n =
11), predictive validity (n = 6), divergent validity (n = 4)
and face validity (n = 4). For 25 instruments, the authors
did not specify or name the type of validity tested. Most
authors reported several types of validity. Validity was
most frequently assessed with a correlational approach.
Responsiveness
The assessment of responsiveness was reported for 20
instruments only (19.2%). Several methods were used.
MID
Only 3 development studies reported on the MID
(2.9%).
Summary of initial validation assessments according to aim
of instrument
Table 3 refers to the instruments for which an aim was
clearly described before the instrument was developed
(n = 49, some studies described more than one aim).
The table shows the number and percentage of instru-
ments which assessed each psychometric property. The
majority of instruments with a defined aim assessed
validity in the initial validation process, regardless of the
kind of aim, whereas test-retest was assessed for fewer
instruments. For 40.6% of the instruments with an eva-
luative aim, responsiveness was assessed and the MID
for 6.3%.
Discussion
Our systematic review showed that there are many
existing PRO instruments measuring various dimensions
of physical activity, highlighting the importance of this
concept as an outcome measure. The methodological
quality of the development process varied considerably
across the 104 included instruments. For the majority of
the instruments, the aim either was not clearly described
or not described at all before the instruments were
developed. In addition, patients were often not involved
in the item identification process of new instruments,
making the adaptation of existing scales, unsystematic
literature searches and/or expert input the only sources
of item generation. Several instruments used quantita-
tive patient input for item selection, but a surprisingly
high number of studies did not describe or report on
how items were selected. Also, the quality of the initial
validation varied widely between the instruments. Inter-
nal consistency and test-retest reliability were assessed
more frequently than responsiveness to change. The
MID was estimated for only 3 instruments. Some instru-
ments defined an evaluative aim; however, responsive-
ness was assessed in less than half of these. Many
studies assessed construct validity while content validity
was assessed for only a minority of the instruments.
Table 1 Sources of item identification of the included
instruments (n = 104)
1)
Sources of item identification n %
Adaptation of existing scales only 18 17.3%
Patients & experts & literature (unsystematic search)
1) 13 12.5%
Patients only 12 11.5%
Literature only (unsystematic search) 10 9.6%
Experts and literature (unsystematic search) 7 6.7%
Patients and literature (unsystematic search) 6 5.8%
Adaptation and literature (unsystematic search) 4 3.8%
Patients and experts 4 3.8%
Experts only 3 2.9%
Experts and adaptation and literature (unsystematic search) 2 1.9%
Patients and adaptation 2 1.9%
Adaptation and literature (systematic search) 1 1%
Adaptation and experts 1 1%
Patients and adaptation and literature (unsystematic search) 1 1%
Patients and experts and adaptation 1 1%
Significant others and literature (unsystematic search) and
adaptation
11 %
Not reported/not clearly described 18 17.3%
1) For data extraction details, please see Additional file 1
Table 2 Source and method for item selection of the
included instruments (n = 104)
1)
Source and method for item selection n % n %
Selection with patient input 58 55.8%
Patients quantitative 21 20.2%
Patients qualitative 13 12.5%
Patients qualitative and quantitative 6 5.8%
Patients quantitative and experts
qualitative
6 5.8%
Patients and experts qualitative 5 4.8%
Patients and experts quantitative 4 3.8%
Patients and experts qualitative, patients
quantitative
3 2.9%
Selection with expert input only 12 11.5%
Qualitative 5 4.8%
Quantitative 5 4.8%
Quantitative and qualitative 2 1.9%
Not reported (n = 33) and N/A (n = 1) 34 32.7%
1) For data extraction details, please see Additional file 1
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were traditionally used predominantly in epidemiological
research to measure physical activity as a potential
determinant of health outcomes [1,2]. This requires that
the instruments are able to discriminate between people
in order to identify different levels of physical activity
that might be associated with different health outcomes.
In recent years, there has been growing interest in phy-
sical activity as a PRO measure. For example in obesity
research, studies examine the effect of interventions on
physical activity [118-120]. The use of physical activity
i n s t r u m e n t sa so u t c o m em e a s ures has implications for
the development and initial validation process of these
scales. Since PROs should be able to detect changes
over time, their evaluative power is essential. Conse-
quently, development and initial validation studies
should go beyond cross-sectional studies and assess
responsiveness to change and the MID in prospective
follow-up studies [7].
PROs for symptoms, health-related quality of life but
also for physical activity have become a prevalent out-
come in clinical trials. Over the last ten years many new
PROs have been developed and validated and it can be
expected that in the near future an increasing number
of claims on the effectiveness of drugs will be made
based on PROs. As a consequence, both the U.S. Food
and Drug Administration (FDA) and the European Med-
icines Agency (EMA) have developed guidance docu-
ments on the requirements for PRO instruments that
would allow making drug claims. A key evaluation point
for the FDA is the evidence on content validity. Content
validity describes the extent of how the instrument mea-
sures the concept of interest, which is specific to the
population, condition and treatments to be studied. The
FDA explicitly asks for patient input for item generation
through qualitative research to ensure content validity
in the development process of a new instrument
[121-123].
Although all of the PRO instruments included in this
systematic review were developed before the finalisation
of the FDA guidance document in December 2009, it is
still surprising that in less than one third of the included
studies authors reported on qualitative research for item
generation such as patient interviews or focus groups,
and a minority declared explicitly to have tested content
validity of the newly developed instruments. These find-
ings, along with the fact of poor reporting on item selec-
tion methods, indicate that only few physical activity
PRO instruments would currently fulfil the FDA and
EMA requirements for outcome measures. While the
need to establish content validity has been recognised
for many years, there has been little pressure to conduct
qualitative research as illustrated in our systematic
review. This is likely to change; at least in the field of
clinical trials as investigators developing new instru-
ments can now follow the FDA and EMA guidance to
establish content validity more formally through qualita-
tive research. Existing instruments are in a more diffi-
cult position, although they may in retrospect support
their relevance to patients through additional qualitative
research. For example, one may examine whether the
constructs measured by existing instruments align with
what patients perceive to be important, or if important
aspects are missing.
One strength of this systematic review was the adher-
ence to rigorous systematic review methodology along
with the broad search strategy to identify existing physi-
cal activity instruments and subscales/domains. We sup-
plemented the systematic database searches by a
comprehensive hand search as well as by a PROQolid
database search. As we aimed to identify any relevant
instruments, we kept the inclusion criteria broad by
using the definition for physical activity as described in
the “2008 Physical activity guideline for Americans” [3].
Such a broad perspective could also be perceived as a
limitation. Although we paid great attention to carefully
defining the inclusion criteria, we cannot exclude the
possibility of having missed questionnaires. Also, the
decision about inclusion or exclusion of the instruments
was sometimes ambiguous as for example for instru-
ments assessing specific types of physical activity for
chronic illnesses such as multiple sclerosis or chronic
pain. In such cases we tried to adopt systematically and
scientifically defendable decision criteria for inclusion or
Table 3 Conducted initial validation assessments according to described aims of instruments
1)
Described aim of instrument Test-retest Internal consistency Validity Responsiveness MID
2)
n%
3) n%
3) n%
3) n%
3) n%
3)
Evaluative (n = 33) 23 69.7% 21 63.6% 32 96.9% 13 39.4% 2 6.1%
Discriminative (n = 26) 15 57.7% 18 69.2% 24 92.3% 6 23.1% 1 3.8%
Planning (n = 13) 11 84.6% 7 53.8% 12 92.3% 3 23.1% 1 7.7%
Predictive (n = 5) 1 20.0% 0 0% 3 60.0% 0 0% 0 0%
1) For data extraction details, please see Additional file 1
2) MID = Minimal important difference
3) % in relation to the corresponding aim
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we did not consider physical activity instruments aiming
at impaired hand motor activity but we included those
assessing physical activity limitations which are more
general and which could also be relevant for other
chronic illnesses like “Walking ability” [54] or “Physical
functioning” [93]. Another example includes activity
limitations due to pain, where we excluded some instru-
ments such as those targeting specialised pain coping
activities, but included instruments such as the Activ-
ities of Daily Living Scale [71]. We focused solely on
publications of the development and initial validation,
which to some extent may underestimate the rigour of
the overall development process. Undoubtedly some
instruments might have had additional validation studies
which we have not included in this review. However, we
suspect that many instruments were introduced into
research and practice rather rapidly without further vali-
dation, and, if validations were conducted during the
development process, it is likely that the authors would
have published these results as part of the development
paper.
Conclusion
Our systematic review showed that there are many
existing PRO instruments measuring physical activity in
chronically ill and elderly patient populations, highlight-
ing the importance of this concept as an outcome mea-
sure. However, the development processes often lacked
definitions of the instruments’ aims and patient input. If
PROs for physical activity are to be used in clinical
trials, there needs to be more focus on establishing con-
tent validity through patient input, and assessing their
evaluative measurement properties.
Additional material
Additional file 1: Data extraction results: Development and initial
validation process of the reviewed instruments. Summary of the
extracted data for the development and initial validation process of the
reviewed instruments according to the categories aim of instruments,
identification of items, selection of items (item reduction), development
of domains, test-retest, internal consistency, validity, responsiveness and
MID.
Additional file 2: References list of excluded articles after full text
assessment. List of all references of articles which have been excluded
after full text assessment.
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